BioCentury
ARTICLE | Company News

Flexus Biosciences, Bristol-Myers deal

April 13, 2015 7:00 AM UTC

Bristol-Myers Squibb completed its acquisition of Flexus for $800 million up front and up to $450 million in development milestones (see BioCentury, March 2). ...